After 20 years, liver transplantation comes of age.
نویسندگان
چکیده
WHrT£ OJ. ed. Cydosporin A: Proccedinp of the IntenutiotW Symposium. Cambridp. Amsterdam: Elsevier Biomedic:al Publishen; 1912:3544. 2. KAHAN BD. RJED M. NEWBEaGEa J. Phannacokinetica of eyeloaporine in hullWl rcnal transplantation. Tran."umt Prot:. 1983;15:446-53. 3. WHrT£ OJ. Cyeiosporin A: clinical phU1lUlC01OU and therapeutic p0tential Drop. 1982;14:322-34. 4. KAMAN BD. Mcctinc Report: the First International Consrcsa on Cyelosporinc: Houston. Tcxu: May 16-19, 1983. Dial Tl3IUpIMJt. 1983;12:620-30. 5. VoH WILLEBRAND E. HAYRY P. Cyclosporin-A deposita in renal aJ1o.. grafts. Une«. 1983;1: 189-92. . ' 6. SIBLEY RK. FEaGUSON RM. SUTHERLAND DE. SIMMONS RL. NAJARIAN J8. MorphololY of cyelosporine nephrotoaicity and of acute rcjI:clion in eyclosporinc-prednisone immunosuppressed renal allograft recipients. Trespw.t Proc. 1983. (In pnsa). . 7. WAGNER E. PICHYLMAYR R. WORIGEIT K. KLEMPNAUER J, BUNZENDAHL H. l.AUCHART W. Differentiation between rejection and cyclosporin A ncphrotoaicity by monitorinl interstitial pressure in hullWl renal alloarafla. T17UISpWJt Proc. 1983;15:489-928. flAMILTON DV. CALNE RY. EVANS DB. HENDERSON RG. THIRU S. WHrT£ OJ. The cfl'ect of lon8-term eyelosporin A on renal function [Letter}. LMw«. 1981;1:1218-9. 9. NAJARIAN JS. FERGUSON RM. SUTHERLAND DE. RYNASIEWICZ JT. SIMMONS RL. A prospective trial of the dlicacy of cyclosporine in rcnal transplantation at the University of Minnesota. T17UISpw.t Prot:. 1983;15:438-41. 10. HAMILTON DV. EVANS DB. THIRU S. Toxicity of cyclosporin A in organ grafting. In: WHITE OJ. ed. CycJosporin A: Pract:t:dinp of tlu: lnremacion.l Symposium, Cambridge. Amsterdam: ElscVier Biomedical Publishers; 1982:393-411. 11. VENKATACHALAM MA. PathololY of acute renal failure. In: BRENNER B. STEIN J. cds. Chronic Ren.l Failure. New York: Churchill-Livinlstone; 1981:79-107. 12. FARNSWORTH A, HALL BM. KIRWAN P. et al. Pathology in renal transplant patients treated with cyclosporin A. Transplant Proc. 1983. (In press). 13. MIHATSCH Ml. OLIVIERI W. MARBET U. THIEL G. HARDER F. ZOLLINGER HU. Giant mitochondria in renal tubular cells and cyclosporin A [Letter}. Uncet. 1981;1:1162-3. 14. SHULMAN H. STRIKER G. DEEG HJ. KENNEDY M. STORB R. THOMAS ED. Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomcnalar thromboses and tubular injury. N En6I J MtItL 1981;305:ll92-'. 15. LEITHNER C. SINZlNGEIl H. POHANKA E. ScHWARZ M, KRETSCHMU G, SYRE G. Recum:ncc of haemolytic uraemic syndrome trigcred by cye1osporin A after renal transplantation [Letter). LMw«. 1982;1:1470. 16. GREENBERG A, EGa J. THOMPSON M. ct al. Renal failUft in hean transplant paticDta receiving cyclosporin A (Abstl'lCt}. au. Ra 1983;31:429A. 17. Joss DV. BARRETT AJ. KENDRA JR. LUCAS cr. DESAI S. Hypcnca. sion and CORvillsiona in children receiving cyclosporin A [Letter). Lucet. 1982;1:906. 18. ADU D. "ftJIlNEY J, MICHAEL J, McMASTER P. HypcrkaIumia ia cyo. losporin-llated renal allogtaft recipients. Lmcet. 1983;2:370-219. STILLER CR, KEOWN PA. SINCLAIR NR. ULAN RA.lmmunc resp0nses and pharmacokinetics in the human renal allograft recipient treated with c)'closporin A. In: WHITE OJ. ed. Cyclosporin A: Prot:«dinp 01" the Inter7UltioniU Symposium, Cambridge. Amsterdam: E1sevier Biomedical Publishers; 1982:379-86. 20. KENNEDY MS, DEW HJ, SIEGEL M. CROWLEY JJ. STORB R. THOMAS ED. Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation. Transp/llnl.tioa.. 1983;35:211-5. 21. FERGUSON RM. SUTHERLAND DE. SIMMONS RL. NAJARIAN JS. Ketoconazole. cyclosporin metabolism. and renal transplantation [Letter). LMw«. 1982;1:882-3. 22.. WHmNG PH. THOMSON A W, BLAIR IT. SIMPSON JG. Experimental cyelosporin A nephrotoxicity. Br J up PathoJ. 1982;63:88-94. 23. R YFFEL B. Experimental toxlcological studies with cyclosporin A. In: WHITE OJ. cd. Cyclosporin A: ProceedingS oflhe InlerutiolW Symposium. Cambridge. Amsterdam: Elsevier Biomedical Publishers; 1982:4575. 24. BAXTER CR. DUGGIN GO. WILLIS NS. HALL BM. HORVATH IS, TILLER OJ. Cyclosporin A-induced increases in renin siorage and releuc. Res Commun Chem PathoJ PhlU7ll.coJ. 1982;37:305-122!5. KIRWAN PD. BAXTER CR. DUGGIN GG. ct aI. Giant mitcbondria, renal transplant biopsy. and cyc1osporin A [leiter). Uncet. 1981;2:146. 26. CUNNINGHAM C. BURKE MD. WHITING PH. SIMPSON JG. WHEATLEY ON. Ketoconazole. cyclosporin. and the kidney [Letter). 1982;1:1464. 27. SHIEL AGR. HALL BM. TILLER OJ. et al. Australian trial of cyclosporin A in cadaveric donor transplantation. TnnspIMJt Prot:. 1983. (In press). 01983 American College of Physicians
منابع مشابه
Investigation of KCNJ11 Gene Variant (rs 5219) in Patients with Diabetes after Liver Transplantation
Background & Objective: The incidence of diabetes in liver transplant recipients is one of the common problems among these patients witha negative effect on the success of the transplant and the patient's life. Post Transplant Diabetes Mellitus (PTDM) has many similarities with type 2 diabetes from pathophysiplogical, clinical, and genetic viewpoints... One of the genotypes involved in PTD...
متن کاملپیوند همزمان کبد و کلیه در بیمار مبتلا به نارسایی کبدی و کلیوی در یک بیمار 18 ساله
Introduction: Over the years, renal insufficiency caused by liver disorders was an obstacle to liver transplantation in these patients. After presenting a system for the evaluation of various stages of liver disease, simultaneous transplantation of the liver and kidney is considered an appropriate therapeutic treatment in patients who are at the end stage of the liver disease and have secondary...
متن کاملLIVING-RELATED LIVER TRANSPLANTATION IN CHILDREN: THE SHIRAZ EXPERIENCE
The liver transplantation program was established at Shiraz Nemazee Hospital in 1993. Shortage of cadaver organ supply due to various social and legal issues urged us to develop a living-related liver transplantation (LRLT) program. So far 7 (6 males, 1 female) living-related liver transplantations have been performed at this center. The mean age of patients was 8.21 years (+/- 4.16), with ...
متن کاملRecipient Age and Mortality Risk after Liver Transplantation: A Population-Based Cohort Study
The aim of the present large population-based cohort study is to explore the risk factors of age-related mortality in liver transplant recipients in Taiwan. Basic information and data on medical comorbidities for 2938 patients who received liver transplants between July 1, 1998, and December 31, 2012, were extracted from the National Health Insurance Research Database on the basis of ICD-9-code...
متن کاملRecent Technological Advances in Hepatogenic Differentiation of Stem Cells Relevant to Treatment of Liver Diseases
Liver failure, in an acute or chronic form, is a growing health problem ranking as one of the leading causes of death worldwide. Inborn errors of metabolism characterized by defects in hepatic enzymes or other proteins with metabolic functions, such as receptors or transporters accompanied with environmental factors involve etiology and presentation of liver failure. Currently, the only establi...
متن کاملFive-Year Experience of Liver Transplant at Kerman University of Medical Sciences: Afzalipoor Hospital
Introduction: The only option for treatment of end stage liver diseases is liver transplantation. Afzalipour Hospital in Kerman, Iran is the third largest liver transplantation center in Iran. In this study, the outcomes of this center have been studied during the past 5 years. Methods: In this cross-sectional study, the pre and post transplantation’s clinical, demographic and outcome data of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Annals of internal medicine
دوره 99 6 شماره
صفحات -
تاریخ انتشار 1983